Background. Diabetic foot ulceration is a devastating complication of diabetes mellitus and is a major source of morbidity and mortality. So far, there are few published data on diabetic foot ulcers and its determinants among diabetic patients on follow-up at Jimma Medical Center. Hence, the aim of this study was to assess the prevalence of diabetic foot ulcer and its determinants among patients with diabetes mellitus at Jimma Medical Center. Methods. A hospital-based cross-sectional study was conducted from June 1 to August 30, 2019, and systematic random sampling technique was applied. The total number of study subjects who participated in the study was 277. Data were collected using an interview-administered structured questionnaire. Data were entered into EpiData version 3.1 and exported to SPSS version 20 software for analysis. Analysis was done using descriptive statistics and logistic regression. A variable having a p value of <0.25 in the bivariate model was subjected to multivariate analysis to avoid confounding the variable's effect. Adjusted odds ratios (AOR) were calculated at 95% confidence interval and considered significant with a p value of ≤0.05. Result. The mean of age of participants was 50:1 ± 14:19 years. More than threefourths of participants (82.7%) were type 2 DM. The mean duration of diabetic patients was 6:00 ± 5:07 years. The prevalence of diabetic foot ulcer was 11.6% among study participants. According to multivariate logistic regression analysis, previous history of ulceration (AOR = 5:77; 95% CI: 2.37, 14.0) and peripheral neuropathy (AOR = 11:2; 95% CI: 2.8, 44.4) were independent predictors of diabetic foot ulcer. Conclusion. The prevalence of diabetic foot ulcer was 11.6%. Previous history of ulceration and peripheral neuropathy were associated with diabetic foot ulcer. The health care providers are recommended to thoroughly give emphasis during follow-up of patients who had previous history of ulceration and peripheral neuropathy in order to decrease the occurrence of diabetic foot ulcer.
Introduction
Diabetes has reached epidemic proportions worldwide. The International Diabetes Federation (IDF) estimates 425 million people living with DM worldwide in 2017, estimated to rise to 628 million by 2045. Sub-Saharan Africa is currently enduring the heaviest global burden of diabetes [1, 2] .
Diabetic foot disease (DFD) is one of the diabetic complications associated with major morbidity, mortality, and reduced quality of life and is the most serious complication of diabetes mellitus [3, 4] . The incidence of DFD is still rising [5] . According to the international consensus on diabetic foot, a foot ulcer is defined as a full-thickness wound below the ankle in a diabetic patient, irrespective of duration [6] .
The International Diabetes Federation estimates that at least one limb is lost due to DFU somewhere in the world every 30 seconds [7] . DFU is the most common cause of hospitalization in diabetic patients and also has significant socioeconomic impact [8, 9] . It is estimated that a person with diabetes has a 25% lifetime risk of developing DFU [10] . Patients with DFU have a greater than twofold increase in mortality compared with nonulcerated diabetic patients [11] . Five-year mortality rates after ulceration were around 40% [3] . Furthermore, the DFD and its long-term sequelae account for direct medical expenditures and lengthy periods of disability [12] .
According to a systematic review in 2017, the prevalence of foot ulcers among diabetic patients ranges from 3% to 13% globally [13] . In Africa, with constrained resources, the prevalence of DFU is higher. In sub-Saharan Africa, the burden of DFU is increasing due to late diagnosis, poor awareness among patients, and poor access to health care [13, 14] .
DFU is preventable, and frequency of lower limb amputations can be lowered by 49-87% by preventing the development of DFU. Evidence in the literature suggests that the early detection and treatment of diabetic foot complications could reduce the prevalence of ulceration by 44% to 85% [15, 16] . Increased age, male gender, peripheral vascular disease, peripheral neuropathy, and renal disease were common risk factors for death after ulceration [3] . Patients at risk of developing DFU can easily be identified by clinical examination of the feet during follow-up [17] . Early screening of high-risk patients is important to prevent development of foot ulcers and its associated morbidity. To date, data regarding prevalence and factors related to foot ulcers among diabetic patients in Jimma are relatively few, and point prevalence varies in previous studies. So, the aim of this study is to solve this gap.
Methods

Study Area and Period.
This study was conducted in Jimma Medical Center (JMC) which is located in Jimma town, Jimma zone, 355 km to the southwest of Addis Ababa, the capital city of Ethiopia. JMC is one of the largest hospitals in our country serving a very large catchment area in the Southwestern Oromia region. It gives different specialized clinical services including chronic follow-up for diabetes mellitus, hypertension, and other chronic illnesses. The study was conducted from June 1 to August 30, 2019.
Study
Design. An institution-based cross-sectional study was conducted among adult diabetic patients on the followup clinic at Jimma Medical Center. 2.4. Eligibility Criteria. Participants of age ≥ 18 years were included, and those who were seriously ill, gestational diabetic, diabetic patients who had traumatic ulcer, and clinically suspected of having Charcot foot were excluded.
Operational
Definition. Diabetic foot ulcer: these are nontraumatic lesions of the skin on the foot distal to malleoli of a person who has diabetes mellitus.
Clinically suspected patient with Charcot foot: patients having DM for a long period of time and presented with a low level of sensation, swelling, and foot associated with midfoot collapse.
Peripheral neuropathy: this is defined as a patient with history version of MNSI questionnaire score ≥ 7, abnormal responses in the legs and/or if the lower extremity examination version of MNSI scores ≥2.5 in the legs [18] .
Foot deformities: these are the presence of any of the following structural abnormalities in one or both feet: hammer toes, claw-toes, hallux valgus, prominent metatarsal heads, and amputations.
2.6. Sample Size Calculation and Sampling Procedure. The sample size was calculated using single population proportion formula by considering the prevalence of diabetic foot ulcer in Gondar, Ethiopia at 13.6% [19] at 95% confidence level and a 4% margin of error. It gives an initial sample size of 280. Since the source population of diabetic patients at the JMC clinic is less than 10,000, about 2500, by using the population correction formula for a finite population, the final sample size was calculated to be 251. By taking into consideration a 10% nonresponse rate, the final sample size was 277.
A systematic random sampling technique was employed to select study participants. The diabetes clinic runs twice weekly, and there were about 2500 diabetic patients on follow-up taken from the diabetes mellitus outpatient unit manager. These patients were our sampling frame, and the patients included in the sample were selected at every ninth interval. We got the interval by dividing the source population (2500) to the final sample size (277) and obtained nine. The first patient was selected randomly from the first ninth by a lottery method, and the next patient was interviewed and examined every ninth interval until the required sample was attained.
Data Collection
Tool. Data were collected through a validated, pretested, and structured questionnaire which was developed after reviewing different literatures. The questionnaire contains sociodemographic factors, behavioral variables, clinical variables, and anthropometric measurements.
Clinical variables were taken from the patient record review, and anthropometric measurements were measured. Body weight was measured while wearing light clothes by an adjusted weight scale. Height was measured by meter, standing upright on a flat surface. Behavioral variables were assessed based on the WHO STEPwise approach for chronic disease risk factor surveillance [20] . BMI was calculated as kg/m 2 to determine the nutritional status of the participant. Data collection was carried out by 2 BSC nurses and one medical intern with supervision of the principal investigator. After overnight fasting, blood samples were obtained for laboratory evaluation. The Michigan Neuropathy Screening Instrument was used to evaluate the presence of diabetic peripheral neuropathy (DPN) [21] .
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Journal of Diabetes Research 2.8. Data Analysis. The collected data were checked for completeness and coded. Then, the data were entered into Epi-Data version 3.1 and then exported to SPSS version 20.0 for analysis. Descriptive statistics such as frequencies, percentages, means, and standard deviations were computed as necessary. Bivariate and multivariate logistic regression models were used to determine the degree of association between the outcome and predictor variables. Variables having a p value of <0.25 in the bivariate model were subjected to multivariate analysis to avoid confounding the variables' effect.
The goodness of fit of the multivariate model was checked with the Hosmer and Lemeshow test (p = 0:32). p value ≤ 0.05 was taken as statistically significant.
2.9. Data Quality Assurance. Data quality was ensured through standardized data collection materials, and questionnaires were thoroughly checked for completeness and consistency. To ensure the quality of data and cultural acceptance of the tool, pretests of data collection tools were carried out on 14 diabetes patients attending the Shenen Gibe hospital diabetic clinic prior to actual data collection. After analyzing pretest results, necessary modifications and corrections were made. Every day, the collected data was checked for completeness. Consequently, amendments and corrections were made.
Ethical Consideration.
Ethical clearance was obtained from the Jimma University Institutional Review Board. A supportive formal letter was written to Jimma Medical Center. Data collection was done after permissions were obtained from hospital managers, and oral informed consent was obtained from the study participants to start data collection.
Result
3.1. Sociodemographic Characteristics of Participants. A total of two hundred and seventy-seven participants were involved in this study. More than half (165) of the respondents were males and the rest (112) were females. The mean age of the respondents was 50:1 ± 14:28 years. Regarding the marital status of the respondents, more than three-fourths (224, 80.9%) were married followed by singles (44, 15.9%) ( Table 1) . 
Clinical and Behavioral Characteristics of Participants.
Greater than three-fourths (82.7%) of the participants were type 2 DM. More than half (56.3%) of them were diagnosed with diabetes for less than 5 years, and almost one-third (31%) had no comorbid hypertension. A total of 189 (68.2%) of the study participants were in the normal category of BMI, whereas 44 (15.9%) of the participants were overweight. One hundred twenty-nine (46.6%) had diabetic peripheral neuropathy (Table 2 ).
Factors Independently Associated with Diabetic Foot
Ulcer. Diabetic patients who had peripheral neuropathy were 11.2 times more likely to develop diabetic foot ulcer as compared with those who had no peripheral neuropathy (AOR = 11:2; 95% CI 2.8, 44.4; p = 0:001). Likewise, diabetic patients who had a history of ulceration were 5.77 times more likely to develop diabetic foot ulcer as compared with those who had no history of ulceration (p value = 0.00; AOR = 5:77; 95% CI 2.37, 14.0) provided other factors remain the same (Table 3 ).
Discussion
In the present study, the prevalence of diabetic foot ulcers among diabetic patients attending JMC was 11.6% (95% CI: 7.9, 15.5). This finding is in line with three independent studies done in Ethiopia, 13.6% in Gondar, 12% in Mekelle, and 14.8% in Arbaminch [19, 22, 23] . In addition, similar finding in North India (14.3%) and in Tanzania (15%) [24, 25] . However, this finding was lower than the study done in Addis Ababa, Ethiopia (31.1%) [26] ; Telangana, India (16%) [27] ; and Jordan (4.6%) [28] . The possible reason for such discrepancy might be due to difference in sample size used, study design, knowledge about foot selfcare, health-seeking behavior, and health infrastructure of study participants.
In contrast, the finding of the current study is higher than a study conducted in Kenya which reported 4.6% [29] ; Wollo, Ethiopia (4.4%) [30] ; and Ghana which was 3.8% [31] . The possible difference might be due to difference in sample size, study design, and eligibility criteria.
The current finding demonstrated that participants who had peripheral neuropathy were 11.2 times more likely to develop diabetic foot ulcer than diabetic patients without peripheral neuropathy (AOR = 11:2; 95% CI: 2. 8, 44.4) . This result is consistent with prior studies [19, 27] .This association is possibly because DPN promotes ulcer formation by causing loss of protective pain sensation, loss of pressure perception, and impairment of microcirculation [32, 33] . Journal of Diabetes Research Furthermore, according to the current finding, participants who had a history of foot ulceration were 5.77 times more likely to develop diabetic foot ulcer than those without a previous history of foot ulceration (AOR = 5:77; 95% CI: 2.37, 14). The result is consistent with prior studies in Ghana and England [31, 34] . This association can be explained by biomechanical factors such as the degree of barefoot and in-shoe mechanical stress and the level of adherence to wearing prescribed footwear. In addition, it may be due to the fact that ulcer leads to microvascular dysfunction, macrovascular dysfunction, and peripheral nerve damage [35] .
Conclusion
The prevalence of diabetic foot ulcer was 11.6% among study participants. Previous history of ulceration and peripheral neuropathy were independent predictors of diabetic foot ulcer. The health care providers are recommended to give emphasis during follow-up of patients who had a previous history of ulceration and manage the neuropathy thoroughly in order to decrease the occurrence of diabetic foot ulcer. In addition, future efforts should be directed toward educating both the healthcare professionals and patients about proper foot care.
5.1.
Limitation of the Study. The duration of diabetes as measured in this study might not reflect the true duration of the disease, because the time since diagnosis and actual diabetes onset might precede diagnosis type 2 diabetes. Another limitation is the cross-sectional nature of the study which does not confirm the definitive cause and effect relation.
We did not asses the vascular status of our study population, so that we could not asses the prevalence of peripheral arterial disease.
